Ensysce Biosciences, Inc.
ENSC
$2.11
$0.052.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.91% | 1.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.91% | 1.23% | |||
| Cost of Revenue | 2.01% | -50.42% | |||
| Gross Profit | 2.44% | 77.36% | |||
| SG&A Expenses | -14.50% | 30.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.03% | -32.64% | |||
| Operating Income | 11.03% | 44.99% | |||
| Income Before Tax | 10.90% | 45.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.90% | 45.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.91% | 45.42% | |||
| EBIT | 11.03% | 44.99% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 43.32% | 52.12% | |||
| Normalized Basic EPS | 43.32% | 52.12% | |||
| EPS Diluted | 43.32% | 52.12% | |||
| Normalized Diluted EPS | 43.32% | 52.12% | |||
| Average Basic Shares Outstanding | 57.18% | 13.99% | |||
| Average Diluted Shares Outstanding | 57.18% | 13.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||